These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 7654733)

  • 21. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.
    Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J
    J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation.
    Li L; Avery R; Budev M; Mossad S; Danziger-Isakov L
    J Heart Lung Transplant; 2012 Aug; 31(8):839-44. PubMed ID: 22621746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients.
    Soghikian MV; Valentine VG; Berry GJ; Patel HR; Robbins RC; Theodore J
    J Heart Lung Transplant; 1996 Sep; 15(9):881-7. PubMed ID: 8889983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
    Whimbey E; Champlin RE; Englund JA; Mirza NQ; Piedra PA; Goodrich JM; Przepiorka D; Luna MA; Morice RC; Neumann JL
    Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary infections with respiratory syncytial virus and the parainfluenza viruses.
    Henderson FW
    Semin Respir Infect; 1987 Jun; 2(2):112-21. PubMed ID: 2827280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric heart-lung transplantation: intermediate-term results.
    Conte JV; Robbins RC; Reichenspurner H; Valentine VG; Theodore J; Reitz BA
    J Heart Lung Transplant; 1996 Jul; 15(7):692-9. PubMed ID: 8820785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit].
    Kalayoglu Beşişik S; Sen F; Midilli K; Yilmaz G; Ozsüt H; Calangu S; Sargin D
    Mikrobiyol Bul; 2008 Apr; 42(2):359-64. PubMed ID: 18697436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients.
    Poonyagariyagorn HK; Gershman A; Avery R; Minai O; Blazey H; Asamoto K; Alster J; Murthy S; Mehta A; Pettersson G; Mason DP; Budev M
    Transpl Infect Dis; 2008 Dec; 10(6):403-8. PubMed ID: 18823356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory syncytial virus infection following hematopoietic stem cell transplantation.
    Small TN; Casson A; Malak SF; Boulad F; Kiehn TE; Stiles J; Ushay HM; Sepkowitz KA
    Bone Marrow Transplant; 2002 Feb; 29(4):321-7. PubMed ID: 11896429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza B virus infection in pediatric solid organ transplant recipients.
    Mauch TJ; Bratton S; Myers T; Krane E; Gentry SR; Kashtan CE
    Pediatrics; 1994 Aug; 94(2 Pt 1):225-9. PubMed ID: 8036078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin.
    McColl MD; Corser RB; Bremner J; Chopra R
    Bone Marrow Transplant; 1998 Feb; 21(4):423-5. PubMed ID: 9509980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung transplantation for cystic fibrosis: 6-year follow-up.
    Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
    J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of acquired diffuse bronchomalacia in heart-lung transplant recipients with obliterative bronchiolitis.
    Novick RJ; Ahmad D; Menkis AH; Reid KR; Pflugfelder PW; Kostuk WJ; McKenzie FN
    J Thorac Cardiovasc Surg; 1991 Apr; 101(4):643-8. PubMed ID: 2008102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: case report and review of the literature.
    Flynn JD; Akers WS; Jones M; Stevkovic N; Waid T; Mullett T; Jahania S
    Pharmacotherapy; 2004 Jul; 24(7):932-8. PubMed ID: 15303457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orthomyxoviral and paramyxoviral infections in transplant patients.
    Sable CA; Hayden FG
    Infect Dis Clin North Am; 1995 Dec; 9(4):987-1003. PubMed ID: 8747776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Outcomes of Paramyxovirus Infections in Lung Transplant Recipients Treated With Oral Ribavirin: A Two-Center Case Series.
    Garcia B; Sharma N; Johnson K; Salgado J; Wille K
    Exp Clin Transplant; 2019 Jun; 17(3):393-397. PubMed ID: 29108516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
    Khanna N; Widmer AF; Decker M; Steffen I; Halter J; Heim D; Weisser M; Gratwohl A; Fluckiger U; Hirsch HH
    Clin Infect Dis; 2008 Feb; 46(3):402-12. PubMed ID: 18181739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy.
    Chakrabarti S; Collingham KE; Holder K; Oyaide S; Pillay D; Milligan DW
    Clin Infect Dis; 2000 Dec; 31(6):1516-8. PubMed ID: 11096028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in invasive disease due to Candida species following heart and lung transplantation.
    Schaenman JM; Rosso F; Austin JM; Baron EJ; Gamberg P; Miller J; Oyer PE; Robbins RC; Montoya JG
    Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.